These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30521056)

  • 1. Use of Systemic Treatment in Patients with Chronic Pruritus: A Survey of Dermatologists in the Netherlands.
    Kouwenhoven TA; van de Kerkhof PCM; Kamsteeg M
    Acta Derm Venereol; 2019 Mar; 99(3):304-308. PubMed ID: 30521056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription Practices Regarding the use of Systemic Drugs in the Management of Patients with Chronic Pruritus amongst Indian Dermatologists - A Questionnaire Based Survey.
    Vyas K; Maheshwari K; Reddy PKS; Verma R; Hasan I; Mittal A
    Indian Dermatol Online J; 2024; 15(1):33-38. PubMed ID: 38283019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants as antipruritic agents: A review.
    Kaur R; Sinha VR
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):341-352. PubMed ID: 29456150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin and oral antidepressants for chronic pruritus: a prospective cohort study evaluating efficacy and side effects in daily dermatological practice.
    Kouwenhoven TA; van de Kerkhof PCM; Kamsteeg M
    J Dermatolog Treat; 2023 Dec; 34(1):2274291. PubMed ID: 37905412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants.
    Soni A; Walters P
    Int J Prison Health; 2019 Aug; 16(1):67-77. PubMed ID: 32040271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of oral antidepressants in patients with chronic pruritus: A systematic review.
    Kouwenhoven TA; van de Kerkhof PCM; Kamsteeg M
    J Am Acad Dermatol; 2017 Dec; 77(6):1068-1073.e7. PubMed ID: 29033248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety considerations when using drugs to treat pruritus.
    Fourzali K; Yosipovitch G
    Expert Opin Drug Saf; 2020 Apr; 19(4):467-477. PubMed ID: 32064980
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands.
    Njoo MD; Bossuyt PM; Westerhof W
    Int J Dermatol; 1999 Nov; 38(11):866-72. PubMed ID: 10583624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.
    Pereira MP; Basta S; Moore J; Ständer S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2224-2229. PubMed ID: 29869425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pruritus in the elderly: management by senior dermatologists.
    Fleischer AB
    J Am Acad Dermatol; 1993 Apr; 28(4):603-9. PubMed ID: 8463462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pruritus in childhood. A diagnostic and therapeutic challenge].
    Weisshaar E; Seeliger S; Diepgen TL; Luger TA; Ständer S
    Hautarzt; 2004 Sep; 55(9):855-68. PubMed ID: 15340711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of prescribing isotretinoin: focus on women of childbearing potential.
    Doering PL; Araujo OE; Frohnapple DJ; LaMarre AS; Flowers FP
    Ann Pharmacother; 1992 Feb; 26(2):155-61. PubMed ID: 1554922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
    Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
    Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gabapentin and doxepin in the management of uremic pruritus: A randomized crossover clinical trial.
    Haber R; Bachour J; Salloum A; Maacaron T; Khoury F; Habr L; Ammoury A; Joubran N
    Dermatol Ther; 2020 Nov; 33(6):e14522. PubMed ID: 33176043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation of doxepin for intractable pruritus.
    Beck KM; Yang EJ; Koo J
    J Am Acad Dermatol; 2018 Sep; 79(3):e37. PubMed ID: 30119870
    [No Abstract]   [Full Text] [Related]  

  • 16. [Topical therapy of pruritus-tips for daily practice].
    Salzmann S; Staubach P
    Hautarzt; 2020 Jul; 71(7):511-517. PubMed ID: 32399669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rational symptomatic therapy for chronic pruritus].
    Ständer S
    Hautarzt; 2006 May; 57(5):403-10. PubMed ID: 16583225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic itch in systemic disease. Current standards].
    Mettang T; Ständer S; Kremer AE
    Internist (Berl); 2015 Dec; 56(12):1369-78. PubMed ID: 26585238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation.
    Manenti L; Vaglio A; Costantino E; Danisi D; Oliva B; Pini S; Prati E; Testori A
    J Nephrol; 2005; 18(1):86-91. PubMed ID: 15772928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of pruritus.
    Ständer S; Weisshaar E
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.